Fundraising Fox

Oak HC/FT2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Precision Medicine Group HoldingsFeb 2018SEC filingmedium confidence

HealthtechBethesda, US

Ethan Leder(Executive Officer, Director)Mark Clein(Executive Officer, Director)Paul Vigano(Director)Charles T. Clark(Executive Officer)Jesse Glossner(Executive Officer)John B. Mariano, Jr.(Executive Officer)

Board seatAnnie Lamont· per SEC Form D · filed Mar 2020

Syllablesyllable.aiinAug 2018

Syllable is a platform for building, running, and optimizing production AI agents, offering a no-code conversational builder for domain experts and declarative configurations and APIs for engineering teams.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSunnyvale, US

Sarel Kobus Jooste(Executive Officer, Director)Guilherme Medeiros Bastos(Executive Officer)

Co-investorsMemorialCare Innovation FundNew Enterprise Associates (NEA)TCV

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.